<http://webisa.webdatacommons.org/prov/310955789>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/97324965> .
<http://webisa.webdatacommons.org/97324965>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<thisisms.com> .
<http://webisa.webdatacommons.org/97324965>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/97324965>	<http://www.w3.org/ns/prov#value>	"by patientx ?? Fri Jan 16, 2009 9:44 am Clinicians and regulators worry over side effects, particularly the risk of developing a rare neurological condition progressive multifocal leukoencephalopathy (PML)" .